Multiple switches between GP2015, an etanercept biosimilar, with originator product do not impact efficacy, safety and immunogenicity in patients with chronic plaque-type psoriasis: 30-week results from the phase 3, confirmatory EGALITY study

S. Gerdes*, D. Thaçi, C. E.M. Griffiths, P. Arenberger, J. Poetzl, G. Wuerth, M. Afonso, H. Woehling

*Korrespondierende/r Autor/-in für diese Arbeit
37 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Multiple switches between GP2015, an etanercept biosimilar, with originator product do not impact efficacy, safety and immunogenicity in patients with chronic plaque-type psoriasis: 30-week results from the phase 3, confirmatory EGALITY study“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medizin & Biologie